News Posts List
Anastomosing hemangioma of the kidney: radiologic and pathologic distinctions of a kidney cancer mimic
07/12/2018
Anastomosing hemangioma (ah) is a rare subtype of primary vascular tumour that can, clinically and radiologically, present similarly to malignant renal tumours such as renal cell carcinoma (rcc) and angiosarcoma.
Targeting tumor-associated acidity in cancer immunotherapy
07/11/2018
Checkpoint inhibitors, such as cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) and programmed cell death-1 (PD-1) monoclonal antibodies have changed profoundly the treatment of melanoma, renal cell carcinoma, non-small cell lung cancer, Hodgkin lymphoma, and bladder cancer. Currently, they are tested in various tumor entities as monotherapy or in combination with chemotherapies or targeted therapies. However, only a subgroup of patients benefit from checkpoint blockade (combinations).
Patients with early kidney cancer see significant benefits with robotic partial nephrectomy
07/11/2018
A comprehensive study by the Keck School of Medicine of USC has found that robotic partial nephrectomy offers significantly better patient outcomes.
This is how a 9-year-old celebrates being cancer free
07/10/2018
Nine-year-old JaKiah Collins had a big doctor's appointment ahead of her. She was used to coming to the hospital; she'd been in and out of hospitals for years. But this appointment was a big milestone.
Immune Checkpoint Blockade in Advanced Renal-Cell Carcinoma
07/05/2018
In the CheckMate 214 trial, Motzer et al found higher overall survival among intermediate- and poor-risk patients with previously untreated metastatic renal-cell carcinoma who received nivolumab plus ipilimumab than among those who received sunitinib
Otago scientists' breakthrough in childhood kidney cancer
07/03/2018
A world-first discovery by University of Otago scientists may change the way children suffering from a rare form of kidney cancer are treated.
The Secrets of Spontaneous Cancer Remission
07/01/2018
Once in a rare while, we hear a story of someone given months or weeks to live who ends up surviving and defiantly thriving. Like the first person to run a four-minute mile, climb Mt. Everest, or walk on the moon, such individuals are living proof that the impossible is possible. Yet because their experience is so far outside the norm, these survivors have been labeled medical anomalies and set aside from the lens of research. That is, until Kelly Turner, PhD, came along. The author of Radical Remission: Surviving Cancer Against All Odds (HarperCollins, 2014), Turner has studied hundreds of spontaneous-remission cases to see what can be learned from them.
Gender May Play a Role in Immunotherapy Efficacy, Further Studies Are Warranted
06/29/2018
Immunotherapy continues to evolve as a treatment option for various cancers; however, men may see more benefit from it more than women, according to a study published in The Lancet Oncology.
A Simpler, Safer Option For Treating Kidney Cancer
06/29/2018
Many cases of early-stage kidney cancer can be treated with a relatively new, nonsurgical procedure used to destroy tumors, a new study by a team led by Weill Cornell Medicine and NewYork-Presbyterian suggests. The procedure, called percutaneous ablation, involves the insertion of a needle.
Robotic surgery is no better than traditional surgery, study finds
06/29/2018
Robotic-assisted procedures have now become ubiquitous in some kinds of surgeries. What once was seen as a technological marvel is commonplace in many hospitals. But studies in recent years have shown robotic surgery performs no better than traditional surgery - even though it comes at a steeper cost to the overall health-care system.
News Feed